ABBV vs. HCA: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and HCA, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing HCA’s 91.85 billion USD by roughly 3.50×.
HCA carries a higher beta at 1.47, indicating it’s more sensitive to market moves, while ABBV remains steadier at 0.55.
| Symbol | ABBV | HCA |
|---|---|---|
| Company Name | AbbVie Inc. | HCA Healthcare, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Care Facilities |
| CEO | Mr. Robert A. Michael CPA | Mr. Samuel N. Hazen |
| Price | 181.8 USD | 381.81 USD |
| Market Cap | 321.13 billion USD | 91.85 billion USD |
| Beta | 0.55 | 1.47 |
| Exchange | NYSE | NYSE |
| IPO Date | January 2, 2013 | March 10, 2011 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABBV and HCA over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ABBV and HCA based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- HCA carries a sub-zero price-to-book ratio of -27.06, indicating negative equity. In contrast, ABBV (P/B 226.35) has positive book value.
| Symbol | ABBV | HCA |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 76.62 | 16.48 |
| Forward PEG Ratio (TTM) | 7.16 | 1.23 |
| Price-to-Sales Ratio (P/S, TTM) | 5.60 | 1.28 |
| Price-to-Book Ratio (P/B, TTM) | 226.35 | -27.06 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | 18.56 |
| EV-to-EBITDA (TTM) | 23.58 | 9.76 |
| EV-to-Sales (TTM) | 6.73 | 1.92 |
| EV-to-Free Cash Flow (TTM) | 25.08 | 27.73 |
Dividend Comparison
ABBV’s dividend yield of 3.51% is about 396% higher than HCA’s 0.71%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | ABBV | HCA |
|---|---|---|
| Dividend Yield (TTM) | 3.51% | 0.71% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and HCA, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ABBV’s current ratio of 0.76 signals a possible liquidity squeeze, while HCA at 1.19 comfortably covers its short-term obligations.
- ABBV’s quick ratio of 0.64 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas HCA at 1.06 maintains a comfortable buffer of liquid assets.
- ABBV carries high leverage (debt-to-equity ratio 49.22), whereas HCA has negative equity (-13.20), each presenting distinct capital-structure concerns.
| Symbol | ABBV | HCA |
|---|---|---|
| Current Ratio (TTM) | 0.76 | 1.19 |
| Quick Ratio (TTM) | 0.64 | 1.06 |
| Debt-to-Equity Ratio (TTM) | 49.22 | -13.20 |
| Debt-to-Assets Ratio (TTM) | 0.51 | 0.78 |
| Interest Coverage Ratio (TTM) | 6.14 | 5.17 |